Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

281 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
POEMS Syndrome-Clinical Picture and Management. Current Knowledge.
Jurczyszyn A, Olszewska-Szopa M, Vesole D. Jurczyszyn A, et al. Among authors: vesole d. Clin Lymphoma Myeloma Leuk. 2023 Aug;23(8):575-582. doi: 10.1016/j.clml.2023.04.008. Epub 2023 Apr 26. Clin Lymphoma Myeloma Leuk. 2023. PMID: 37210272 Review.
Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients.
Avivi I, Vesole DH, Davila-Valls J, Usnarska-Zubkiewicz L, Olszewska-Szopa M, Milunovic V, Baumert B, Osękowska B, Kopińska A, Gentile M, Puertas-Martinez B, Robak P, Crusoe E, Rodriguez-Lobato LG, Gajewska M, Varga G, Delforge M, Cohen Y, Gozzetti A, Pena C, Shustik C, Mikala G, Zalac K, Alexander HD, Barth P, Weisel K, Martínez-López J, Waszczuk-Gajda A, Krzystański M, Jurczyszyn A. Avivi I, et al. Among authors: vesole dh. Cancers (Basel). 2023 Sep 1;15(17):4359. doi: 10.3390/cancers15174359. Cancers (Basel). 2023. PMID: 37686635 Free PMC article.
Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment-67 Patients Multicenter Analysis.
Charliński G, Steinhardt M, Rasche L, Gonzalez-Calle V, Peña C, Parmar H, Wiśniewska-Piąty K, Dávila Valls J, Olszewska-Szopa M, Usnarska-Zubkiewicz L, Gozzetti A, Ciofini S, Gentile M, Zamagni E, Kurlapski M, Legieć W, Vesole DH, Jurczyszyn A. Charliński G, et al. Among authors: vesole dh. Cancers (Basel). 2024 Apr 21;16(8):1592. doi: 10.3390/cancers16081592. Cancers (Basel). 2024. PMID: 38672674 Free PMC article.
Prognostic factors and clinical characteristics of patients with newly diagnosed non-secretory multiple myeloma in the era of new drugs in "real-world" study: Experiences of the Polish Myeloma Group.
Charliński G, Szudy-Szczyrek A, Podgajna M, Mielnik M, Kopińska A, Tyczyńska A, Usnarska-Zubkiewicz L, Bołkun Ł, Wiater E, Krzystański M, Vesole DH, Jurczyszyn A. Charliński G, et al. Among authors: vesole dh. Adv Clin Exp Med. 2024 Aug 29. doi: 10.17219/acem/189390. Online ahead of print. Adv Clin Exp Med. 2024. PMID: 39206811
Post-ASCT consolidation with elotuzumab, lenalidomide, and dexamethasone or elotuzumab, pomalidomide, and dexamethasone in high-risk and ultra-high-risk multiple myeloma: a retrospective single-center study.
Zolotov E, Kabat M, Parmar H, Anand P, Zenreich J, Aleman A, Phull P, Doucette K, Vesole DH, Siegel DS, Biran N. Zolotov E, et al. Among authors: vesole dh. Leuk Lymphoma. 2024 Dec;65(13):2000-2008. doi: 10.1080/10428194.2024.2385501. Epub 2024 Jul 31. Leuk Lymphoma. 2024. PMID: 39082756
281 results